In contrast, according to the J-ROCKET AF study, rivaroxaban, which is a factor Xa inhibitor, tended to slightly increase gastrointestinal bleeding in patients aged 75 years and older, when compared to warfarin [23]. This evidence concerns the gene F10 and atrial fibrillation.